本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Bioventus Inc.

7.82
+0.04000.51%
盤後7.820.00000.00%19:36 EDT
成交量:32.36萬
成交額:251.96萬
市值:5.17億
市盈率:-15.05
高:7.88
開:7.74
低:7.59
收:7.78
資料載入中...
2024/06/17

重要事件披露

Form 8-K - Current report
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/23

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/12

重要事件披露

Form 8-K - Current report
2024/01/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/21

重要事件披露

Form 8-K - Current report
2023/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report